Clinical trials
Withdrawn Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Colorado, Denver | 2 |
| Actelion | 1 |
| AmMax Bio, Inc. | 1 |
| Biosplice Therapeutics, Inc. | 1 |
| Blade Therapeutics | 1 |
| Dr. Christopher Lambers | 1 |
| Hoffmann-La Roche | 1 |
| Imperial College London | 1 |
| Modern Biosciences Ltd | 1 |
| NYU Langone Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 16 |
| Pulmonary Arterial Hypertension | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
| Anemia, Sickle Cell | 1 |
| Cystic Fibrosis | 1 |
| Hemophilia A | 1 |
| Hemophilia B | 1 |
| Hypertension, Pulmonary | 1 |
| Lung Diseases, Interstitial | 1 |
| Myasthenia Gravis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.